Literature DB >> 23730991

Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years.

Yong Wei1, Zhimin Jin, Guoying Shen, Xiaowei Zhao, Wanhua Yang, Ye Zhong, Jiguang Wang.   

Abstract

This study was performed to investigate whether intensive antihypertensive treatment with achieved blood pressure (BP) ≤140/90 mm Hg, as compared with standard treatment with achieved BP ≤150/90 mm Hg, could further improve cardiovascular outcomes in Chinese hypertensive patients older than 70 years. A total of 724 participants were randomly assigned to intensive or standard antihypertensive treatment. After a mean follow-up of 4 years, the mean achieved BP was 135.7/76.2 mm Hg in the intensive treatment group and 149.7/82.1 mm Hg in the standard treatment group. The visit-to-visit variability in systolic BP and diastolic BP was lower in the intensive group than that in the standard group. Intensive antihypertensive treatment, compared with the standard treatment, decreased total and cardiovascular mortality by 41.7% and 50.3%, respectively, and reduced fatal/nonfatal stroke by 42.0% and heart failure death by 62.7%. Cox regression analysis indicated that the mean systolic BP (P=.020; 95% confidence interval, 1.006-1.069) and the standard deviation of systolic BP (P=.033; 95% confidence interval, 1.006-1.151) were risk factors for cardiovascular endpoint events. Intensive antihypertensive treatment with achieved 136/76 mm Hg was beneficial for Chinese hypertensive patients older than 70 years. Long-term visit-to-visit variability in systolic BP was positively associated with the incidence of cardiovascular events.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23730991      PMCID: PMC8033887          DOI: 10.1111/jch.12094

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

Review 1.  Guidelines for treatment of hypertension in the elderly--2002 revised version.

Authors:  Toshio Ogihara; Kunio Hiwada; Shigeto Morimoto; Hiroaki Matsuoka; Masayuki Matsumoto; Shuichi Takishita; Kazuaki Shimamoto; Kazuyuki Shimada; Isao Abe; Yasuyoshi Ouchi; Hisaichiro Tsukiyama; Shigehiro Katayama; Yutaka Imai; Hiromichi Suzuki; Katsuhiko Kohara; Kohya Okaishi; Hiroshi Mikami
Journal:  Hypertens Res       Date:  2003-01       Impact factor: 3.872

2.  Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.

Authors:  Patrick Rossignol; Joelle Cridlig; Philippe Lehert; Michèle Kessler; Faiez Zannad
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

3.  Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.

Authors:  Giuseppe Mancia; Rita Facchetti; Michele Bombelli; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

4.  New concepts in hypertension: focus on the elderly.

Authors:  H R Black
Journal:  Am Heart J       Date:  1998-02       Impact factor: 4.749

5.  Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations.

Authors:  Tine W Hansen; Lutgarde Thijs; Yan Li; José Boggia; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

6.  Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  R H Fagard; J A Staessen
Journal:  Clin Exp Hypertens       Date:  1999 Jul-Aug       Impact factor: 1.749

7.  [2010 Chinese guidelines for the management of hypertension].

Authors:  Li-Sheng Liu
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2011-07

8.  Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

Authors: 
Journal:  Hypertens Res       Date:  2008-12       Impact factor: 3.872

Review 9.  Recent clinical trials in atrial fibrillation in hypertensive patients.

Authors:  Athanasios J Manolis; Manolis S Kallistratos; Leonidas E Poulimenos
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

10.  Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years.

Authors:  Yong Wei; Zhimin Jin; Guoying Shen; Xiaowei Zhao; Wanhua Yang; Ye Zhong; Jiguang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-04       Impact factor: 3.738

View more
  22 in total

1.  Effect of intensive lowering of systolic blood pressure treatment on heart failure events: a meta-analysis of randomized controlled studies.

Authors:  Yun Zhang; Mingming Liang; Chenyu Sun; Guangbo Qu; Tingting Shi; Min Min; Yile Wu; Yehuan Sun
Journal:  J Hum Hypertens       Date:  2019-07-30       Impact factor: 3.012

2.  Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.

Authors:  Mattias Brunström; Bo Carlberg
Journal:  JAMA Intern Med       Date:  2018-01-01       Impact factor: 21.873

Review 3.  Evidenced-Based Nutrition for Gestational Diabetes Mellitus.

Authors:  Amita Mahajan; Lois E Donovan; Rachelle Vallee; Jennifer M Yamamoto
Journal:  Curr Diab Rep       Date:  2019-08-31       Impact factor: 4.810

Review 4.  Hypertension Management at Older Age: An Update.

Authors:  Rita Del Pinto; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-11-22

Review 5.  Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.

Authors:  Rakesh Malhotra; Hoang Anh Nguyen; Oscar Benavente; Mihriye Mete; Barbara V Howard; Jonathan Mant; Michelle C Odden; Carmen A Peralta; Alfred K Cheung; Girish N Nadkarni; Ruth L Coleman; Rury R Holman; Alberto Zanchetti; Ruth Peters; Nigel Beckett; Jan A Staessen; Joachim H Ix
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

Review 6.  The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension.

Authors:  Chern-En Chiang; Tzung-Dau Wang; Tsung-Hsien Lin; Hung-I Yeh; Ping-Yen Liu; Hao-Min Cheng; Ting-Hsing Chao; Chen-Huan Chen; Kou-Gi Shyu; Kwo-Chang Ueng; Chung-Yin Chen; Pao-Hsien Chu; Shih-Hsien Sung; Kang-Ling Wang; Yi-Heng Li; Kuo-Yang Wang; Fu-Tien Chiang; Wen-Ter Lai; Jyh-Hong Chen; Wen-Jone Chen; San-Jou Yeh; Ming-Fong Chen; Shing-Jong Lin; Jiunn-Lee Lin
Journal:  Acta Cardiol Sin       Date:  2017-05       Impact factor: 2.672

7.  Clinical outcomes and economic impact of the 2017 ACC/AHA guidelines on hypertension in China.

Authors:  Zengwu Wang; Guang Hao; Xin Wang; Zuo Chen; Linfeng Zhang; Zugui Zhang; Hao Hu; William S Weintraub; Runlin Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-03       Impact factor: 3.738

8.  Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis.

Authors:  Chi-Jung Huang; Chern-En Chiang; Bryan Williams; Kazuomi Kario; Shih-Hsien Sung; Chen-Huan Chen; Tzung-Dau Wang; Hao-Min Cheng
Journal:  Am J Hypertens       Date:  2019-01-15       Impact factor: 2.689

9.  Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years.

Authors:  Yong Wei; Zhimin Jin; Guoying Shen; Xiaowei Zhao; Wanhua Yang; Ye Zhong; Jiguang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-04       Impact factor: 3.738

10.  Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Ling Zhang; Xiuting Sun; Lizhen Liao; Shaozhao Zhang; Huimin Zhou; Xiangbin Zhong; Xiaodong Zhuang; Xinxue Liao
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-31       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.